Company Filing History:
3 out of 243 
3 out of 2,597 
Years Active: 2013-2014
Title: Nadia Dahmane: Innovator in Cancer Treatment
Introduction
Nadia Dahmane is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of cancer research, holding a total of 3 patents. Her work focuses on developing innovative compounds and methods for the prevention and treatment of cancer.
Latest Patents
Nadia's latest patents include groundbreaking inventions aimed at combating cancer. One of her notable patents is titled "Compounds and methods for the prevention and treatment of cancer." This invention relates to compounds that modulate sonic hedgehog signaling, which plays a crucial role in cancer development. Another significant patent is "Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer." This invention involves steroid-derived cyclopamine analogs that inhibit sonic hedgehog signaling, providing a method for synthesizing these analogs from steroids.
Career Highlights
Throughout her career, Nadia has worked with esteemed institutions such as The Wistar Institute and the University of Pennsylvania. Her research has been pivotal in advancing the understanding of cancer treatment methodologies.
Collaborations
Nadia has collaborated with notable colleagues, including Jeffrey Winkler and Andre Isaacs. These partnerships have further enriched her research and contributed to her innovative work in cancer treatment.
Conclusion
Nadia Dahmane's contributions to cancer research through her patents and collaborations highlight her dedication to improving treatment options. Her innovative approaches continue to inspire advancements in the field of oncology.